Prime Medicine, Inc. - COMMON STOCK (PRME)

CUSIP: 74168J101

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
181,672,212
Total 13F shares
41,322,385
Share change
+41,284,776
Total reported value
$767,784,036
Price per share
$18.58
Number of holders
65
Value change
+$767,085,261
Number of buys
64

Quarterly Holders Quick Answers

What is CUSIP 74168J101?
CUSIP 74168J101 identifies PRME - Prime Medicine, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Prime Medicine, Inc. - COMMON STOCK (PRME) as of Q4 2022

As of 31 Dec 2022, Prime Medicine, Inc. - COMMON STOCK (PRME) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,322,385 shares. The largest 10 holders included Alphabet Inc., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Redmile Group, LLC, MWG Management Ltd., FIL Ltd, ARK Investment Management LLC, BlackRock Inc., BAKER BROS. ADVISORS LP, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). This page lists 65 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.